Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial

Rodney P E Pollard; Wayel H Abdulahad; Arjan Vissink; Nishath Hamza; Johannes G M Burgerhof; Jiska M Meijer; Annie Visser; Minke G Huitema; Fred K L Spijkervet; Cees G M Kallenberg; Hendrika Bootsma; Frans G M Kroese

doi:10.1136/annrheumdis-2012-202071

Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial

Rodney P E Pollard, Wayel H Abdulahad, Arjan Vissink, Nishath Hamza, Johannes G M Burgerhof, Jiska M Meijer, Annie Visser, Minke G Huitema, Fred K L Spijkervet, Cees G M Kallenberg, Hendrika Bootsma, Frans G M Kroese

Research output: Contribution to journal › Article › Academic › peer-review

54 Citations (Scopus)

Original language	English
Pages (from-to)	146-8
Number of pages	3
Journal	Annals of the Rheumatic Diseases
Volume	72
Issue number	1
DOIs	https://doi.org/10.1136/annrheumdis-2012-202071
Publication status	Published - Jan-2013

Keywords

Antibodies, Monoclonal, Murine-Derived
Antirheumatic Agents
B-Cell Activating Factor
Double-Blind Method
Enzyme-Linked Immunosorbent Assay
Humans
Sjogren's Syndrome
Tumor Necrosis Factor Ligand Superfamily Member 13

Access to Document

10.1136/annrheumdis-2012-202071

Cite this

Pollard, R. P. E., Abdulahad, W. H., Vissink, A., Hamza, N., Burgerhof, J. G. M., Meijer, J. M., Visser, A., Huitema, M. G., Spijkervet, F. K. L., Kallenberg, C. G. M., Bootsma, H., & Kroese, F. G. M. (2013). Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial. Annals of the Rheumatic Diseases, 72(1), 146-8. https://doi.org/10.1136/annrheumdis-2012-202071

Pollard, Rodney P E ; Abdulahad, Wayel H ; Vissink, Arjan ; Hamza, Nishath ; Burgerhof, Johannes G M ; Meijer, Jiska M ; Visser, Annie ; Huitema, Minke G ; Spijkervet, Fred K L ; Kallenberg, Cees G M ; Bootsma, Hendrika ; Kroese, Frans G M. / Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome : data from a placebo-controlled clinical trial. In: Annals of the Rheumatic Diseases. 2013 ; Vol. 72, No. 1. pp. 146-8.

@article{96672e9e55e749deb94be66561fb07f1,

title = "Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial",

keywords = "Antibodies, Monoclonal, Murine-Derived, Antirheumatic Agents, B-Cell Activating Factor, Double-Blind Method, Enzyme-Linked Immunosorbent Assay, Humans, Sjogren's Syndrome, Tumor Necrosis Factor Ligand Superfamily Member 13",

author = "Pollard, {Rodney P E} and Abdulahad, {Wayel H} and Arjan Vissink and Nishath Hamza and Burgerhof, {Johannes G M} and Meijer, {Jiska M} and Annie Visser and Huitema, {Minke G} and Spijkervet, {Fred K L} and Kallenberg, {Cees G M} and Hendrika Bootsma and Kroese, {Frans G M}",

year = "2013",

month = jan,

doi = "10.1136/annrheumdis-2012-202071",

language = "English",

volume = "72",

pages = "146--8",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ PUBLISHING GROUP",

number = "1",

}

Pollard, RPE, Abdulahad, WH , Vissink, A, Hamza, N, Burgerhof, JGM, Meijer, JM, Visser, A, Huitema, MG, Spijkervet, FKL, Kallenberg, CGM, Bootsma, H & Kroese, FGM 2013, 'Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial', Annals of the Rheumatic Diseases, vol. 72, no. 1, pp. 146-8. https://doi.org/10.1136/annrheumdis-2012-202071

Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome : data from a placebo-controlled clinical trial. / Pollard, Rodney P E; Abdulahad, Wayel H ; Vissink, Arjan; Hamza, Nishath; Burgerhof, Johannes G M; Meijer, Jiska M; Visser, Annie; Huitema, Minke G; Spijkervet, Fred K L; Kallenberg, Cees G M; Bootsma, Hendrika ; Kroese, Frans G M.

In: Annals of the Rheumatic Diseases, Vol. 72, No. 1, 01.2013, p. 146-8.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome

T2 - data from a placebo-controlled clinical trial

AU - Pollard, Rodney P E

AU - Abdulahad, Wayel H

AU - Vissink, Arjan

AU - Hamza, Nishath

AU - Burgerhof, Johannes G M

AU - Meijer, Jiska M

AU - Visser, Annie

AU - Huitema, Minke G

AU - Spijkervet, Fred K L

AU - Kallenberg, Cees G M

AU - Bootsma, Hendrika

AU - Kroese, Frans G M

PY - 2013/1

Y1 - 2013/1

KW - Antibodies, Monoclonal, Murine-Derived

KW - Antirheumatic Agents

KW - B-Cell Activating Factor

KW - Double-Blind Method

KW - Enzyme-Linked Immunosorbent Assay

KW - Humans

KW - Sjogren's Syndrome

KW - Tumor Necrosis Factor Ligand Superfamily Member 13

U2 - 10.1136/annrheumdis-2012-202071

DO - 10.1136/annrheumdis-2012-202071

M3 - Article

C2 - 22851468

VL - 72

SP - 146

EP - 148

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 1

ER -